DrugPatentWatch Database Preview
Guerbet Company Profile
Email this page to a colleague
See Plans and PricingWhat is the competitive landscape for GUERBET, and what generic and branded alternatives to GUERBET drugs are available?
GUERBET has four approved drugs.
Summary for Guerbet
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 4 |
| NDAs: | 4 |
| Drug Master File Entries: | 1 |
Drugs and US Patents for Guerbet
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guerbet | DOTAREM | gadoterate meglumine | SOLUTION;INTRAVENOUS | 204781-003 | Mar 20, 2013 | AP | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Guerbet | DOTAREM | gadoterate meglumine | SOLUTION;INTRAVENOUS | 204781-002 | Mar 20, 2013 | AP | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Guerbet | DOTAREM | gadoterate meglumine | SOLUTION;INTRAVENOUS | 204781-005 | Mar 31, 2017 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Guerbet | OXILAN-300 | ioxilan | INJECTABLE;INJECTION | 020316-001 | Dec 21, 1995 | DISCN | No | No | Start Trial | Start Trial | |||||
| Guerbet | DOTAREM | gadoterate meglumine | SOLUTION;INTRAVENOUS | 204781-001 | Mar 20, 2013 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Guerbet
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,014,986 | Start Trial |
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,094,966 | Start Trial |
| Guerbet | OXILAN-300 | ioxilan | INJECTABLE;INJECTION | 020316-001 | Dec 21, 1995 | 4,954,348 | Start Trial |
| Guerbet | OXILAN-350 | ioxilan | INJECTABLE;INJECTION | 020316-002 | Dec 21, 1995 | 4,954,348 | Start Trial |
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,065,553 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
